Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/58218
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNicholls S.J.-
dc.contributor.authorPavo I.-
dc.contributor.authorD'Alessio D.-
dc.date.accessioned2026-05-06T22:44:03Z-
dc.date.available2026-05-06T22:44:03Z-
dc.date.copyright2026-
dc.date.issued2026-04-21en
dc.identifier.citationThe New England journal of medicine. 394(15) (no pagination), 2026. Date of Publication: 16 Apr 2026.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/58218-
dc.relation.ispartofThe New England Journal of Medicine-
dc.subject.meshnon insulin dependent diabetes mellitus-
dc.subject.meshtirzepatide-
dc.titleCardiovascular Outcomes with Tirzepatide in Type 2 Diabetes. Reply.-
dc.typeLetter-
dc.identifier.affiliationCardiology (MonashHeart)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://acs.hcn.com.au/?acc=36265&url=https://dx.doi.org/10.1056/NEJMc2600572-
dc.publisher.placeUnited States-
dc.identifier.pubmedid41985147-
dc.identifier.institution(Nicholls) Victorian Heart Institute, Melbourne, VIC, Australia-
dc.identifier.institution(Pavo) Eli Lilly, Indianapolis, United States-
dc.identifier.institution(D'Alessio) Duke University Medical Center, Durham, NC, United States-
dc.identifier.affiliationmh(Nicholls) Victorian Heart Institute, Melbourne, VIC, Australia-
item.fulltextNo Fulltext-
item.openairetypeLetter-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
crisitem.author.deptCardiology (MonashHeart & Victorian Heart Institute)-
Appears in Collections:Articles
Show simple item record

Page view(s)

66
checked on May 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.